The promises of low dose IL-2 therapy for autoimmune and inflammatory diseases - 2017
 |
Speaker BioDavid Klatzmann received his MD and PhD from the Pierre & Marie Curie Medical School, Paris (France). He is Professor of Immunology and Chairman of the Inflammation-Immunopathology-Biotherapy Department at the Pierre & Marie Curie Medical school, Sorbonne University. His research interests are in translational Immunology, with a special focus on TReg cells. He and his group pioneered low-dose IL-2 immunotherapies. He his the coordinator of the DIABIL-2 European consortium investigating low-dose IL-2 in type-1 diabetes. |
No RSVP Required
Refreshments from 3pm
Seminar starts 3.30pm
